• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Membrane-mediated fibrillation and toxicity of the tau hexapeptide PHF6.tau 六肽 PHF6 的膜介导纤维形成和毒性。
J Biol Chem. 2019 Oct 18;294(42):15304-15317. doi: 10.1074/jbc.RA119.010003. Epub 2019 Aug 22.
2
Identification of Aggregation Mechanism of Acetylated PHF6* and PHF6 Tau Peptides Based on Molecular Dynamics Simulations and Markov State Modeling.基于分子动力学模拟和马尔可夫状态建模的乙酰化PHF6*和PHF6 Tau肽聚集机制的鉴定
ACS Chem Neurosci. 2023 Nov 1;14(21):3959-3971. doi: 10.1021/acschemneuro.3c00578. Epub 2023 Oct 13.
3
Structural transitions in tau k18 on micelle binding suggest a hierarchy in the efficacy of individual microtubule-binding repeats in filament nucleation.微胶束结合时 tau k18 的结构转变表明,在微管结合重复片段引发纤维成核的过程中,各个片段的功效存在一定的层次关系。
Protein Sci. 2013 Aug;22(8):1037-48. doi: 10.1002/pro.2290. Epub 2013 Jun 24.
4
On the Tracks of the Aggregation Mechanism of the PHF6 Peptide from Tau Protein: Molecular Dynamics, Energy, and Interaction Network Investigations.追踪 Tau 蛋白中 PHF6 肽的聚集机制:分子动力学、能量和相互作用网络研究。
ACS Chem Neurosci. 2022 Oct 5;13(19):2874-2887. doi: 10.1021/acschemneuro.2c00314. Epub 2022 Sep 26.
5
Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation.基于分子动力学模拟揭示 Tau 蛋白关键六肽(PHF6)自发聚集和模板诱导错误折叠的机制。
ACS Chem Neurosci. 2019 Dec 18;10(12):4810-4823. doi: 10.1021/acschemneuro.9b00488. Epub 2019 Nov 12.
6
Terminal Capping of an Amyloidogenic Tau Fragment Modulates Its Fibrillation Propensity.淀粉样蛋白生成性tau片段的末端封端调节其纤维化倾向。
J Phys Chem B. 2020 Oct 8;124(40):8772-8783. doi: 10.1021/acs.jpcb.0c05768. Epub 2020 Sep 9.
7
Positional effects of phosphorylation on the stability and morphology of tau-related amyloid fibrils.磷酸化位置对tau 相关淀粉样纤维的稳定性和形态的影响。
Biochemistry. 2012 Feb 21;51(7):1396-406. doi: 10.1021/bi201451z. Epub 2012 Feb 7.
8
Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model.紫草素调节 Tau 衍生的 VQIVYK 纤维形成,并改善动物模型中的阿尔茨海默病样症状。
Cell Mol Life Sci. 2020 Jul;77(14):2795-2813. doi: 10.1007/s00018-019-03312-0. Epub 2019 Sep 27.
9
Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation.tau 双螺旋丝核形成基序中的翻译后修饰会破坏微管相互作用和寡聚物形成。
J Biol Chem. 2022 Jan;298(1):101442. doi: 10.1016/j.jbc.2021.101442. Epub 2021 Nov 24.
10
β-Sheet core of tau paired helical filaments revealed by solid-state NMR.固态 NMR 揭示的 tau 双螺旋丝纤维中的β-折叠核心。
J Am Chem Soc. 2012 Aug 29;134(34):13982-9. doi: 10.1021/ja305470p. Epub 2012 Aug 15.

引用本文的文献

1
Effect of Tau Fragment and Membrane Interactions on Membrane Permeabilization and Peptide Aggregation.Tau片段与膜相互作用对膜通透性和肽聚集的影响。
Membranes (Basel). 2025 Jul 13;15(7):208. doi: 10.3390/membranes15070208.
2
Lipidome disruption in Alzheimer's disease brain: detection, pathological mechanisms, and therapeutic implications.阿尔茨海默病大脑中的脂质组破坏:检测、病理机制及治疗意义
Mol Neurodegener. 2025 Jan 27;20(1):11. doi: 10.1186/s13024-025-00803-6.
3
Differential effect of an evolving amyloid and tau pathology on brain phospholipids and bioactive lipid mediators in rat models of Alzheimer-like pathology.阿尔茨海默病样病理大鼠模型中不断进化的淀粉样蛋白和tau 病理学对脑磷脂和生物活性脂质介质的差异影响。
J Neuroinflammation. 2024 Jul 30;21(1):185. doi: 10.1186/s12974-024-03184-7.
4
Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies.脂质代谢的变化与神经原纤维缠结病理的进展在 tau 病中相关。
J Neuroinflammation. 2024 Mar 27;21(1):78. doi: 10.1186/s12974-024-03060-4.
5
β-Bracelets: Macrocyclic Cross-β Epitope Mimics Based on a Tau Conformational Strain.β-手链:基于 Tau 构象应变的大环交叉-β 表位模拟物。
J Am Chem Soc. 2023 Oct 25;145(42):23131-23142. doi: 10.1021/jacs.3c06830. Epub 2023 Oct 16.
6
Membrane-induced tau amyloid fibrils.膜诱导的 tau 淀粉样纤维。
Commun Biol. 2023 Apr 28;6(1):467. doi: 10.1038/s42003-023-04847-6.
7
Molecular Mechanism of Tau Misfolding and Aggregation: Insights from Molecular Dynamics Simulation.tau 蛋白错误折叠和聚集的分子机制:来自分子动力学模拟的见解。
Curr Med Chem. 2024;31(20):2855-2871. doi: 10.2174/0929867330666230409145247.
8
Interaction of Tau construct K18 with model lipid membranes.Tau构建体K18与模型脂质膜的相互作用。
Nanoscale Adv. 2021 Jun 17;3(14):4244-4253. doi: 10.1039/d1na00055a. eCollection 2021 Jul 13.
9
Single-molecule imaging reveals Tau trapping at nanometer-sized dynamic hot spots near the plasma membrane that persists after microtubule perturbation and cholesterol depletion.单分子成像揭示了 Tau 蛋白在靠近质膜的纳米级动态热点处的捕获,这种捕获在微管扰动和胆固醇耗竭后仍然存在。
EMBO J. 2022 Oct 4;41(19):e111265. doi: 10.15252/embj.2022111265. Epub 2022 Aug 25.
10
Amyloids on Membrane Interfaces: Implications for Neurodegeneration.膜界面上的淀粉样蛋白:对神经退行性变的影响。
J Membr Biol. 2022 Dec;255(6):705-722. doi: 10.1007/s00232-022-00245-x. Epub 2022 Jun 7.

本文引用的文献

1
Discovery and characterization of stable and toxic Tau/phospholipid oligomeric complexes.发现并阐明稳定且毒性的 Tau/磷脂寡聚物复合物。
Nat Commun. 2017 Nov 22;8(1):1678. doi: 10.1038/s41467-017-01575-4.
2
Cryo-EM structures of tau filaments from Alzheimer's disease.阿尔茨海默病tau蛋白细丝的冷冻电镜结构
Nature. 2017 Jul 13;547(7662):185-190. doi: 10.1038/nature23002. Epub 2017 Jul 5.
3
Alpha-Synuclein Oligomers-Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders.α-突触核蛋白寡聚体——帕金森病及其他路易体疾病中的神经毒性分子
Front Neurosci. 2016 Sep 5;10:408. doi: 10.3389/fnins.2016.00408. eCollection 2016.
4
High Membrane Curvature Enhances Binding, Conformational Changes, and Fibrillation of Amyloid-β on Lipid Bilayer Surfaces.高膜曲率增强淀粉样β蛋白在脂质双分子层表面的结合、构象变化和纤维化。
Langmuir. 2015 Oct 27;31(42):11549-57. doi: 10.1021/acs.langmuir.5b03332. Epub 2015 Oct 16.
5
Tau binds to lipid membrane surfaces via short amphipathic helices located in its microtubule-binding repeats.Tau通过位于其微管结合重复序列中的短两性螺旋与脂质膜表面结合。
Biophys J. 2014 Sep 16;107(6):1441-52. doi: 10.1016/j.bpj.2014.07.046.
6
CH-π interaction in VQIVYK sequence elucidated by NMR spectroscopy is essential for PHF formation of tau.通过核磁共振波谱学阐明的 VQIVYK 序列中的 CH-π 相互作用对于 tau 的 PHF 形成是必不可少的。
Biopolymers. 2014 May;102(3):288-95. doi: 10.1002/bip.22489.
7
α-Synuclein senses lipid packing defects and induces lateral expansion of lipids leading to membrane remodeling.α-突触核蛋白感知脂质堆积缺陷,并诱导脂质横向扩展,导致膜重塑。
J Biol Chem. 2013 Jul 19;288(29):20883-20895. doi: 10.1074/jbc.M113.478297. Epub 2013 Jun 5.
8
Tau oligomers impair artificial membrane integrity and cellular viability.tau 寡聚物损害人工膜的完整性和细胞活力。
J Biol Chem. 2012 Dec 21;287(52):43223-33. doi: 10.1074/jbc.M112.396176. Epub 2012 Nov 5.
9
Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity.多变量分析淀粉样β寡聚物群体表明孔形成与细胞毒性之间存在联系。
PLoS One. 2012;7(10):e47261. doi: 10.1371/journal.pone.0047261. Epub 2012 Oct 15.
10
Structure and pathology of tau protein in Alzheimer disease.阿尔茨海默病中tau蛋白的结构与病理学
Int J Alzheimers Dis. 2012;2012:731526. doi: 10.1155/2012/731526. Epub 2012 May 29.

tau 六肽 PHF6 的膜介导纤维形成和毒性。

Membrane-mediated fibrillation and toxicity of the tau hexapeptide PHF6.

机构信息

Center for Biomedical Engineering, University of New Mexico, Albuquerque, New Mexico 87131.

Biomedical Engineering Graduate Program, University of New Mexico, Albuquerque, New Mexico 87131.

出版信息

J Biol Chem. 2019 Oct 18;294(42):15304-15317. doi: 10.1074/jbc.RA119.010003. Epub 2019 Aug 22.

DOI:10.1074/jbc.RA119.010003
PMID:31439664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6802503/
Abstract

The aggregation of the tau protein into neurofibrillary tangles is believed to correlate with cognitive decline in several neurodegenerative disorders, including Alzheimer's disease. Recent studies suggest that tau's interactions with the cell membrane could serve as a toxicity pathway and also enhance fibrillation into paired helical filaments (PHFs). Conformational changes associated with tau-membrane interactions are poorly understood, and their characterization could improve our understanding of tau pathogenicity. In this study, we investigated the molecular level structural changes associated with the interaction of the tau hexapeptide PHF6 with model lipid membranes and characterized the effects of these interactions on membrane stability and peptide fibrillation. We used two PHF6 forms, the aggregation-prone PHF6 with N-terminal acetylation (Ac-PHF6) and the non-aggregation prone PHF6 with a standard N terminus (NH-PHF6). We found that both PHF6 peptides are neurotoxic and exhibit similar membrane-mediated changes, consisting of: 1) favorable interactions with anionic membranes, 2) membrane destabilization through lipid extraction, and 3) membrane-mediated fibrillation. The rate at which these changes occurred was the main difference between the two peptides. NH-PHF6 displayed slow membrane-mediated fibrillation after 6 days of incubation, whereas Ac-PHF6 adopted a β-sheet conformation at the surface of the membrane within hours. Ac-PHF6 interactions with the membrane were also accompanied by membrane invagination and rapid membrane destabilization. Overall, our results reveal that membrane interactions could play a critical role in tau toxicity and fibrillation, and highlight that unraveling these interactions is important for significantly advancing the development of therapeutic strategies to manage tau-associated neurodegenerative diseases.

摘要

tau 蛋白的聚集形成神经纤维缠结被认为与几种神经退行性疾病(包括阿尔茨海默病)的认知能力下降有关。最近的研究表明,tau 与细胞膜的相互作用可能作为一种毒性途径,并增强其纤维化形成双螺旋丝(PHF)。与 tau 与细胞膜相互作用相关的构象变化尚未得到充分理解,对其特征的描述可以加深我们对 tau 致病性的理解。在这项研究中,我们研究了与 tau 六肽 PHF6 与模型脂质膜相互作用相关的分子水平结构变化,并描述了这些相互作用对膜稳定性和肽纤维化的影响。我们使用了两种 PHF6 形式,具有 N 端乙酰化(Ac-PHF6)的易于聚集的 PHF6 和具有标准 N 端的不易聚集的 PHF6(NH-PHF6)。我们发现,这两种 PHF6 肽都具有神经毒性,并表现出类似的膜介导变化,包括:1)与阴离子膜的有利相互作用,2)通过脂质提取导致的膜不稳定,3)膜介导的纤维化。这些变化发生的速度是这两种肽之间的主要区别。NH-PHF6 在孵育 6 天后显示出缓慢的膜介导纤维化,而 Ac-PHF6 在数小时内就在膜表面采用β-折叠构象。Ac-PHF6 与膜的相互作用还伴随着膜内陷和快速的膜不稳定。总的来说,我们的结果表明,膜相互作用可能在 tau 毒性和纤维化中起关键作用,并强调阐明这些相互作用对于显著推进治疗策略的开发以管理与 tau 相关的神经退行性疾病非常重要。